{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:24:23Z","timestamp":1791217463164,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","award":["1-10-IN-30"],"award-info":[{"award-number":["1-10-IN-30"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Iowa City VA Health Care System (5101BX00285-07)"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR059115-04"],"award-info":[{"award-number":["AR059115-04"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F30AG043304, UL1RR024979"],"award-info":[{"award-number":["F30AG043304, UL1RR024979"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","translationalres.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.trsl.2015.01.007","type":"journal-article","created":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T04:41:29Z","timestamp":1422420089000},"page":"176-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Evidence for metabolic aberrations in asymptomatic persons with type 2 diabetes after initiation of simvastatin therapy"],"prefix":"10.1016","volume":"166","author":[{"given":"Manish","family":"Suneja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel K.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy A.","family":"Herlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William I.","family":"Sivitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2015.01.007_bib1","series-title":"Standards of care. Diabetes care","year":"2008"},{"key":"10.1016\/j.trsl.2015.01.007_bib2","doi-asserted-by":"crossref","first-page":"C1208","DOI":"10.1152\/ajpcell.00226.2006","article-title":"Statin-induced apoptosis and skeletal myopathy","volume":"291","author":"Dirks","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.trsl.2015.01.007_bib3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11883-007-0050-3","article-title":"Statin myopathy: incidence, risk factors, and pathophysiology","volume":"9","author":"Sewright","year":"2007","journal-title":"Curr Atheroscler Rep"},{"issue":"suppl","key":"10.1016\/j.trsl.2015.01.007_bib4","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/j.mito.2007.03.007","article-title":"Endogenous synthesis of coenzyme Q in eukaryotes","volume":"7","author":"Tran","year":"2007","journal-title":"Mitochondrion"},{"key":"10.1016\/j.trsl.2015.01.007_bib5","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2165\/00002018-200528080-00002","article-title":"The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical\/clinical implications","volume":"28","author":"Hargreaves","year":"2005","journal-title":"Drug Saf"},{"key":"10.1016\/j.trsl.2015.01.007_bib6","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2007.02.049","article-title":"The role of coenzyme Q10 in statin-associated myopathy: a systematic review","volume":"49","author":"Marcoff","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.trsl.2015.01.007_bib7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clpt.2005.03.006","article-title":"High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial","volume":"78","author":"Paiva","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.trsl.2015.01.007_bib8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jacc.2012.09.036","article-title":"Simvastatin effects on skeletal muscle: relation to decreased mitochondrial function and glucose intolerance","volume":"61","author":"Larsen","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.trsl.2015.01.007_bib9","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1001\/archneur.62.11.1709","article-title":"Muscle coenzyme Q10 level in statin-related myopathy","volume":"62","author":"Lamperti","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.trsl.2015.01.007_bib10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0009-8981(96)06357-7","article-title":"Plasma ubiquinol\/cholesterol ratios in patients with hyperlipidaemia, those with diabetes mellitus and in patients requiring dialysis","volume":"253","author":"McDonnell","year":"1996","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.trsl.2015.01.007_bib11","first-page":"324","article-title":"Effect of treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on serum coenzyme Q10 in diabetic patients","volume":"49","author":"Miyake","year":"1999","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.trsl.2015.01.007_bib12","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1001\/jama.2011.860","article-title":"Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis","volume":"305","author":"Preiss","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.trsl.2015.01.007_bib13","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2015.01.007_bib14","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1161\/CIRCULATIONAHA.112.122135","article-title":"Statins and risk of new-onset diabetes mellitus","volume":"126","author":"Shah","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.trsl.2015.01.007_bib15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10557-014-6534-9","article-title":"Lipid-lowering therapies, glucose control and incident diabetes: evidence, mechanisms and clinical implications","volume":"28","author":"Zafrir","year":"2014","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.trsl.2015.01.007_bib16","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1089\/ars.2009.2531","article-title":"Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities","volume":"12","author":"Sivitz","year":"2010","journal-title":"Antioxid Redox Signal"},{"issue":"suppl 1","key":"10.1016\/j.trsl.2015.01.007_bib17","first-page":"S13","article-title":"Standards of medical care in diabetes\u20142009","volume":"32","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.trsl.2015.01.007_bib18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/014860718801200120","article-title":"Calculation of metabolic expenditure and substrate utilization from gas exchange measurements","volume":"12","author":"Westenskow","year":"1988","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.trsl.2015.01.007_bib19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1080\/10715760290021289","article-title":"Ubiquinol and a coenzyme Q reducing system protect platelet mitochondrial function of transfusional buffy coats from oxidative stress","volume":"36","author":"Merlo Pich","year":"2002","journal-title":"Free Radic Res"},{"key":"10.1016\/j.trsl.2015.01.007_bib20","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.2337\/db12-1152","article-title":"Mitochondrial function in diabetes: novel methodology and new insight","volume":"62","author":"Yu","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2015.01.007_bib21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cccn.2003.12.020","article-title":"Simultaneous analysis of coenzyme Q10 in plasma, erythrocytes and platelets: comparison of the antioxidant level in blood cells and their environment in healthy children and after oral supplementation in adults","volume":"342","author":"Niklowitz","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.trsl.2015.01.007_bib22","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1096\/fj.06-7285com","article-title":"Gene expression profiling in the early phases of DMD: a constant molecular signature characterizes DMD muscle from early postnatal life throughout disease progression","volume":"21","author":"Pescatori","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2015.01.007_bib23","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/path.4346","article-title":"Altered RIG-I\/DDX58-mediated innate immunity in dermatomyositis","volume":"233","author":"Suarez-Calvet","year":"2014","journal-title":"J Pathol"},{"key":"10.1016\/j.trsl.2015.01.007_bib24","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.cmet.2011.03.020","article-title":"mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass","volume":"13","author":"Kunkel","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.trsl.2015.01.007_bib25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.trsl.2015.01.007_bib26","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1001\/jama.292.20.2495","article-title":"Trends in cardiovascular complications of diabetes","volume":"292","author":"Fox","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.trsl.2015.01.007_bib27","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines","volume":"63","author":"Stone","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.trsl.2015.01.007_bib28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.taap.2012.01.008","article-title":"Muscle mitochondrial metabolism and calcium signaling impairment in patients treated with statins","volume":"259","author":"Sirvent","year":"2012","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.trsl.2015.01.007_bib29","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1046\/j.1365-2125.1996.04178.x","article-title":"Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate\/pyruvate ratio","volume":"42","author":"De Pinieux","year":"1996","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.trsl.2015.01.007_bib30","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.bbrc.2005.02.070","article-title":"Simvastatin triggers mitochondria-induced Ca2+ signaling alteration in skeletal muscle","volume":"329","author":"Sirvent","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.trsl.2015.01.007_bib31","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0009-9236(95)90266-X","article-title":"Decreases in serum ubiquinone concentrations do not result in reduced levels in muscle tissue during short-term simvastatin treatment in humans","volume":"57","author":"Laaksonen","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.trsl.2015.01.007_bib32","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0002-9149(97)89180-1","article-title":"The effect of simvastatin treatment on natural antioxidants in low-density lipoproteins and high-energy phosphates and ubiquinone in skeletal muscle","volume":"77","author":"Laaksonen","year":"1996","journal-title":"Am J Cardiol"},{"issue":"suppl","key":"10.1016\/j.trsl.2015.01.007_bib33","doi-asserted-by":"crossref","first-page":"s187","DOI":"10.1016\/0098-2997(94)90028-0","article-title":"Exogenous CoQ10 supplementation prevents plasma ubiquinone reduction induced by HMG-CoA reductase inhibitors","volume":"15","author":"Bargossi","year":"1994","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.trsl.2015.01.007_bib34","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jacc.2013.02.074","article-title":"Simvastatin impairs exercise training adaptations","volume":"62","author":"Mikus","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.trsl.2015.01.007_bib35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.atherosclerosis.2004.06.014","article-title":"Statin myotoxicity is associated with changes in the cardiopulmonary function","volume":"177","author":"Phillips","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.trsl.2015.01.007_bib36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/mus.21847","article-title":"Evaluation of skeletal muscle during calf exercise by 31-phosphorus magnetic resonance spectroscopy in patients on statin medications","volume":"43","author":"Wu","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.trsl.2015.01.007_bib37","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1161\/01.str.0000034125.94759.41","article-title":"ACC\/AHA\/NHLBI Clinical Advisory on the use and safety of statins","volume":"33","author":"Pasternak","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.trsl.2015.01.007_bib38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/wsbm.1197","article-title":"Systems analysis of biological networks in skeletal muscle function","volume":"5","author":"Smith","year":"2013","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"10.1016\/j.trsl.2015.01.007_bib39","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nri2852","article-title":"The impact of the extracellular matrix on inflammation","volume":"10","author":"Sorokin","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trsl.2015.01.007_bib40","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.2337\/diabetes.51.10.2944","article-title":"Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes","volume":"51","author":"Kelley","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2015.01.007_bib41","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.2337\/db06-0981","article-title":"Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes","volume":"56","author":"Mogensen","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.trsl.2015.01.007_bib42","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","article-title":"SLCO1B1 variants and statin-induced myopathy\u2014a genomewide study","volume":"359","author":"Link","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2015.01.007_bib43","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1001\/jama.292.21.2585","article-title":"Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs","volume":"292","author":"Graham","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.trsl.2015.01.007_bib44","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.1016\/S0021-9258(18)43600-9","article-title":"Synthesis of delta 2-isopentenyl tRNA from mevalonate in cultured human fibroblasts","volume":"255","author":"Faust","year":"1980","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2015.01.007_bib45","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/MOL.0b013e3283168ecd","article-title":"Effects of ubiquinone (coenzyme Q10) on myopathy in statin users","volume":"19","author":"Schaars","year":"2008","journal-title":"Curr Opin Lipidol"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524415000341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524415000341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T19:41:05Z","timestamp":1651088465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524415000341"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S1931524415000341"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2015.01.007","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence for metabolic aberrations in asymptomatic persons with type 2 diabetes after initiation of simvastatin therapy","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2015.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}